These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35341942)

  • 1. Synthesis, complex formation and corneal permeation of cyclodextrin-modified, thiolated poly(aspartic acid) as self-gelling formulation of dexamethasone.
    Gyarmati B; Dargó G; Áron Szilágyi B; Vincze A; Facskó R; Budai-Szűcs M; Kiss EL; Szente L; Szilágyi A; Balogh GT
    Eur J Pharm Biopharm; 2022 May; 174():1-9. PubMed ID: 35341942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Optimization of In Situ Gelling Mucoadhesive Eye Drops Containing Dexamethasone.
    Szalai B; Jójárt-Laczkovich O; Kovács A; Berkó S; Balogh GT; Katona G; Budai-Szűcs M
    Gels; 2022 Sep; 8(9):. PubMed ID: 36135271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive Cyclodextrin-Modified Thiolated Poly(aspartic acid) as a Potential Ophthalmic Drug Delivery System.
    Budai-Szűcs M; Kiss EL; Szilágyi BÁ; Szilágyi A; Gyarmati B; Berkó S; Kovács A; Horvát G; Aigner Z; Soós J; Csányi E
    Polymers (Basel); 2018 Feb; 10(2):. PubMed ID: 30966235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing ophthalmic delivery of a poorly water soluble drug from an aqueous in situ gelling system.
    Senjoti FG; Timmins P; Conway BR; Smith AM
    Eur J Pharm Biopharm; 2020 Sep; 154():1-7. PubMed ID: 32599271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ gelation of thiolated poly(aspartic acid) derivatives through oxidant-free disulfide formation for ophthalmic drug delivery.
    Szilágyi BÁ; Gyarmati B; Kiss EL; Budai-Szűcs M; Misra A; Csányi E; László K; Szilágyi A
    Colloids Surf B Biointerfaces; 2023 May; 225():113254. PubMed ID: 36996632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(aspartic acid) with adjustable pH-dependent solubility.
    Németh C; Gyarmati B; Abdullin T; László K; Szilágyi A
    Acta Biomater; 2017 Feb; 49():486-494. PubMed ID: 27915021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetradeca-thiolated cyclodextrins: Highly mucoadhesive and in-situ gelling oligomers with prolonged mucosal adhesion.
    Hussain Asim M; Nazir I; Jalil A; Matuszczak B; Bernkop-Schnürch A
    Int J Pharm; 2020 Mar; 577():119040. PubMed ID: 31953091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
    Jansook P; Pichayakorn W; Muankaew C; Loftsson T
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of a novel polymer, the in-situ gelling mucoadhesive thiolated poly(aspartic acid) in ophthalmic drug delivery].
    Horvát G; Budai-Szűcs M; Berkó S; Szabóné-Révész P; Gyarmati B; Szilágyi BÁ; Szilágyi A; Csányi Erzsébet
    Acta Pharm Hung; 2015; 85(4):115-21. PubMed ID: 26964399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrins and derivatives in drug delivery: New developments, relevant clinical trials, and advanced products.
    Kali G; Haddadzadegan S; Bernkop-Schnürch A
    Carbohydr Polym; 2024 Jan; 324():121500. PubMed ID: 37985088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiolated cyclodextrins: Mucoadhesive and permeation enhancing excipients for ocular drug delivery.
    Asim MH; Ijaz M; Mahmood A; Knoll P; Jalil A; Arshad S; Bernkop-Schnürch A
    Int J Pharm; 2021 Apr; 599():120451. PubMed ID: 33675922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiolated cationic poly(aspartamides) with side group dependent gelation properties for the delivery of anionic polyelectrolytes.
    Mammadova A; Gyarmati B; Sárdi K; Paudics A; Varga Z; Szilágyi A
    J Mater Chem B; 2022 Aug; 10(31):5946-5957. PubMed ID: 35723560
    [No Abstract]   [Full Text] [Related]  

  • 13. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans.
    Kristinsson JK; Fridriksdóttir H; Thórisdóttir S; Sigurdardóttir AM; Stefánsson E; Loftsson T
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1199-203. PubMed ID: 8631635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.
    Wu C; Qi H; Chen W; Huang C; Su C; Li W; Hou S
    Yakugaku Zasshi; 2007 Jan; 127(1):183-91. PubMed ID: 17202799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of pre-activated α-cyclodextrin as a mucoadhesive excipient for intra-vesical drug delivery.
    Ijaz M; Prantl M; Lupo N; Laffleur F; Hussain Asim M; Matuszczak B; Bernkop-Schnürch A
    Int J Pharm; 2017 Dec; 534(1-2):339-347. PubMed ID: 29111098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Per-6-Thiolated Cyclodextrins: A Novel Type of Permeation Enhancing Excipients for BCS Class IV Drugs.
    Asim MH; Nazir I; Jalil A; Laffleur F; Matuszczak B; Bernkop-Schnürch A
    ACS Appl Mater Interfaces; 2020 Feb; 12(7):7942-7950. PubMed ID: 31985207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.
    Jansook P; Ritthidej GC; Ueda H; Stefánsson E; Loftsson T
    J Pharm Pharm Sci; 2010; 13(3):336-50. PubMed ID: 21092707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiolated Hydroxypropyl-β-cyclodextrin: A Potential Multifunctional Excipient for Ocular Drug Delivery.
    Grassiri B; Knoll P; Fabiano A; Piras AM; Zambito Y; Bernkop-Schnürch A
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextran-based cyclodextrin polymers: their solubilizing effect and self-association.
    Fülöp Z; Nielsen TT; Larsen KL; Loftsson T
    Carbohydr Polym; 2013 Sep; 97(2):635-42. PubMed ID: 23911495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro testing of thiolated poly(aspartic acid) from ophthalmic formulation aspects.
    Budai-Szű Cs M; Horvát G; Gyarmati B; Szilágyi BÁ; Szilágyi A; Csihi T; Berkó S; Szabó-Révész P; Mori M; Sandri G; Bonferoni MC; Caramella C; Csányi E
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1241-6. PubMed ID: 26556306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.